The private equity-backed anesthesia provider bought and bullied its way to market dominance in Texas, driving up prices for patients, the FTC alleged. The parties have now reached a deal, though USAP will not admit liability.
FTC, US Anesthesia Partners reach settlement in Texas price collusion case